Online citations, reference lists, and bibliographies.
← Back to Search

Targeting Experimental Orthotopic Glioblastoma With Chitosan-based Superparamagnetic Iron Oxide Nanoparticles (CS-DX-SPIONs)

M. Shevtsov, B. Nikolaev, Y. Marchenko, L. Yakovleva, N. Skvortsov, A. Mazur, P. Tolstoy, V. Ryzhov, G. Multhoff
Published 2018 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Background Glioblastoma is the most devastating primary brain tumor of the central nervous system in adults. Magnetic nanocarriers may help not only for a targeted delivery of chemotherapeutic agents into the tumor site but also provide contrast enhancing properties for diagnostics using magnetic resonance imaging (MRI). Methods Synthesized hybrid chitosan-dextran superparamagnetic nanoparticles (CS-DX-SPIONs) were characterized using transmission electron microscopy (TEM) and relaxometry studies. Nonlinear magnetic response measurements were employed for confirming the superparamagnetic state of particles. Following in vitro analysis of nanoparticles cellular uptake tumor targeting was assessed in the model of the orthotopic glioma in rodents. Results CS-DX-SPIONs nanoparticles showed a uniform diameter of 55 nm under TEM and superparamagentic characteristics as determined by T1 (spin-lattice relaxation time) and T2 (spin-spin relaxation time) proton relaxation times. Application of the chitosan increased the charge from +8.9 to +19.3 mV of the dextran-based SPIONs. The nonlinear magnetic response at second harmonic of CS-DX-SPIONs following the slow change of stationary magnetic fields with very low hysteresis evidenced superparamagnetic state of particles at ambient temperatures. Confocal microscopy and flow cytometry studies showed an enhanced internalization of the chitosan-based nanoparticles in U87, C6 glioma and HeLa cells as compared to dextran-coated particles. Cytotoxicity assay demonstrated acceptable toxicity profile of the synthesized nanoparticles up to a concentration of 10 μg/ml. Intravenously administered CS-DX-SPIONs in orthotopic C6 gliomas in rats accumulated in the tumor site as shown by high-resolution MRI (11.0 T). Retention of nanoparticles resulted in a significant contrast enhancement of the tumor image that was accompanied with a dramatic drop in T2 values (P<0.001). Subsequent histological studies proved the accumulation of the nanoparticles inside glioblastoma cells. Conclusion Hybrid chitosan-dextran magnetic particles demonstrated high MR contrast enhancing properties for the delineation of the brain tumor. Due to a significant retention of the particles in the tumor an application of the CS-DX-SPIONs could not only improve the tumor imaging but also could allow a targeted delivery of chemotherapeutic agents.
This paper references
10.1142/9789814540223_0039
Relaxation Effects in Nuclear Magnetic Resonance Absorption
N. Bloembergen (1990)
10.3389/fphar.2017.00166
Targeted Nanotechnology in Glioblastoma Multiforme
T. Glaser (2017)
10.1016/j.msec.2017.02.008
TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy.
Poornima Agrawal (2017)
10.1016/J.CARBPOL.2007.11.007
Chitosan nanoparticles loaded with dorzolamide and pramipexole
Sofia A. Papadimitriou (2008)
10.1016/S1470-2045(17)30194-8
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
M. Weller (2017)
10.1016/j.mri.2014.09.004
Quantitative susceptibility mapping: current status and future directions.
E. Haacke (2015)
10.1021/nl900031y
Mediating tumor targeting efficiency of nanoparticles through design.
Steven D. Perrault (2009)
10.1016/J.BIOMATERIALS.2007.11.014
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.
L. Liu (2008)
10.1016/j.jconrel.2009.03.002
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Anja Zensi (2009)
10.1016/J.JMMM.2012.02.059
Comparative study of heterogeneous magnetic state above TC in La0.82Sr0.18CoO3 cobaltite and La0.83Sr0.17MnO3 manganite
V. Ryzhov (2012)
10.1208/s12249-011-9695-x
Methotrexate-Loaded Chitosan- and Glycolchitosan-Based Nanoparticles: A Promising Strategy for the Administration of the Anticancer Drug to Brain Tumors
A. Trapani (2011)
10.1016/j.ijpharm.2015.09.062
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
G. Lollo (2015)
10.2217/NNM-2016-0307
Targeted brain delivery nanoparticles for malignant gliomas.
M. Pinto (2017)
10.1038/srep16589
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
B. Wang (2015)
10.1016/j.jneumeth.2014.01.034
Molecular susceptibility weighted imaging of the glioma rim in a mouse model
B. Blasiak (2014)
10.1103/PhysRevB.92.014404
Temperature evolution of superparamagnetic clusters in single-crystal La 0.85 Sr 0.15 CoO 3 characterized by nonlinear magnetic ac response and neutron depolarization
A. V. Lazuta (2015)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1148/radiol.10100495
Quantitative MR imaging of brain iron: a postmortem validation study.
C. Langkammer (2010)
Apolipoprotein A-I coating of protamineoligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood–brain barrier
I Kratzer (2007)
10.1158/1535-7163.MCT-06-0480
Interleukin-13 receptor–targeted nanovesicles are a potential therapy for glioblastoma multiforme
A. B. Madhankumar (2006)
10.1001/jama.2015.16669
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
R. Stupp (2015)
10.1109/TMAG.1981.1061188
Preparation of aqueous magnetic liquids in alkaline and acidic media
R. Massart (1981)
On the spurious signal in the longitudinal nonlinear susceptibility of magnets at the second harmonic of excitation frequency
VA Ryzhov (1996)
10.1073/PNAS.96.9.4820
Mitochondrial disease in mouse results in increased oxidative stress.
L. Esposito (1999)
10.2174/1389200217666160607232540
Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
M. Shevtsov (2016)
10.1016/j.ijbiomac.2017.04.105
Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats.
Yurui Xu (2017)
10.1093/neuonc/nor183
Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging.
B. Tomanek (2012)
Immune effects and membrane interaction of chitosan nanoparticles
A Pattani (2009)
10.1002/mrm.20198
Susceptibility weighted imaging (SWI)
E. M. Haacke (2006)
10.1016/j.nano.2014.12.011
VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor.
Maxim A. Abakumov (2015)
10.1021/acs.molpharmaceut.6b01068
Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Yanzuo Chen (2017)
10.1016/S1470-2045(09)70025-7
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
R. Stupp (2009)
10.1016/j.ijpharm.2015.01.051
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
F. Danhier (2015)
10.1186/1471-2342-13-20
Comparison of T2 and T2*-weighted MR molecular imaging of a mouse model of glioma
B. Blasiak (2013)
10.1016/j.jconrel.2015.10.051
70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
M. Shevtsov (2015)
10.1158/0008-5472.CAN-10-1022
EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
C. Hadjipanayis (2010)
10.1002/PAT.1306
Preparation and properties of ionically cross‐linked chitosan nanoparticles
H. Liu (2009)
Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
S. Khan (2008)
10.1088/0031-9112/18/7/018
Introduction to Solid State Physics
A. Plummer (1967)
10.1016/j.carbpol.2016.09.085
Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma.
Yurui Xu (2017)
Preparation and properties of ionically cross-linkedchitosan nanoparticles
H Liu (2009)
10.2147/IJN.S55118
Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors
M. Shevtsov (2014)
Second-harmonic nonlinear response of a cubic ferromagnet in the critical paramagnetic neighborhood of Tc
A. V. Lazuta (1991)
10.1016/J.JCONREL.2006.11.020
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
I. Kratzer (2007)
10.1039/c5bm00011d
Tailoring the surface charge of dextran-based polymer coated SPIONs for modulated stem cell uptake and MRI contrast.
M. Barrow (2015)
10.3390/ijms140815546
Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells
Masatoshi Watanabe (2013)
10.1002/9780470386323
Introduction to Magnetic Materials
B. Cullity (1972)
10.1109/TNB.2007.908987
Superparamagnetic Iron Oxide Nanoparticles (SPIONs): From Synthesis to In Vivo Studies—A Summary of the Synthesis, Characterization, In Vitro, and In Vivo Investigations of SPIONs With Particular Focus on Surface and Colloidal Properties
A. Petri-Fink (2007)
10.1007/S00723-014-0527-5
Magnetic Study of Nanostructural Composite Material Based on Cobalt Compounds and Porous Silicon
V. Ryzhov (2014)
10.1063/1.3057238
The Principles of Nuclear Magnetism
A. Abragam (1961)
10.1016/j.jconrel.2009.11.014
Design of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cells.
Jun Ichiro Jo (2010)
10.1002/smll.201201531
Applications and potential toxicity of magnetic iron oxide nanoparticles.
G. Liu (2013)
10.1080/1061186X.2016.1238091
iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy
C. Liu (2017)
10.1016/j.molonc.2015.01.006
Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ‐irradiation
Forrest M Kievit (2015)
10.1134/1.1469157
The nonlinear magnetic properties of the pseudocubic Nd0.77Ba0.23MnO3 single crystal in the critical paramagnetic region and phase separation
V. Ryzhov (2002)
10.1039/c5nr06521f
Ionizing radiation improves glioma-specific targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 monoclonal antibodies (SPION-cmHsp70.1).
M. A. Shevtsov (2015)



This paper is referenced by
10.1007/978-3-030-06115-9_15
Brain-Targeted Drug Delivery with Surface-Modified Nanoparticles
Sunita Lahkar (2019)
10.1007/978-981-13-8731-9
Nanomedicine in Brain Diseases: Principles and Application
Xue Xue (2019)
10.3390/APP9112219
Chitosan-Based Nanocarriers for Nose to Brain Delivery
B. A. Aderibigbe (2019)
10.3390/cancers12010242
Nano-Therapies for Glioblastoma Treatment
E. Alphandéry (2020)
10.1007/978-3-030-16379-2_15
Nanomaterials and Their Applications in Bioimaging
R. Rani (2019)
10.2147/IJN.S180859
Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2
B. Wang (2018)
10.1007/978-981-13-8731-9_5
Overcoming the Physiopathologic Barriers: Nanoprobes-Mediated Intracranial Glioma Imaging
Heng Liu (2019)
10.1016/j.jconrel.2020.01.009
Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.
L. L. Israel (2020)
10.1002/wnan.1575
Immunoengineering in glioblastoma imaging and therapy.
Steven Zanganeh (2019)
10.4155/tde-2019-0077
Recent advancements in brain tumor targeting using magnetic nanoparticles.
Himanshu Gandhi (2020)
10.21873/anticanres.14619
Potential for Treatment of Glioblastoma: New Aspects of Superparamagnetic Iron Oxide Nanoparticles
Dana Mareková (2020)
10.3390/cancers12071771
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
A. Chillà (2020)
10.1186/s40580-018-0168-8
Therapeutic nanoplatforms and delivery strategies for neurological disorders
Y. Kang (2018)
10.1039/c9bm01880h
Construction of small-sized superparamagnetic Janus nanoparticles and their application in cancer combined chemotherapy and magnetic hyperthermia.
Liqin Xie (2020)
10.1016/j.reactfunctpolym.2019.104430
Chitosan-based nanomedicine for brain delivery: Where are we heading?
C. Pacheco (2020)
10.1016/j.ijpharm.2019.02.012
Chitosan and chitosan coating nanoparticles for the treatment of brain disease
Shuangwen Yu (2019)
10.1007/978-3-030-12919-4_3
Chitosan Derivatives and Grafted Adjuncts with Unique Properties
H. Merzendorfer (2019)
10.1038/s41598-020-72414-8
Comparison of ultrasmall IONPs and Fe salts biocompatibility and activity in multi-cellular in vitro models
Natalia Janik-Olchawa (2020)
10.3390/antibiotics7020046
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
L. S. Arias (2018)
10.3390/ma12030465
Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Functionalization for Biomedical Applications in the Central Nervous System
Shoeb A. Ansari (2019)
10.2174/1381612825666190523105004
Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
S. Kaliamurthi (2019)
10.1016/j.reactfunctpolym.2019.104352
Hyperbranched lipopolymer-folate-stabilized manganese ferrite nanoparticles for the water-soluble targeted MRI contrast agent
Rimesh Augustine (2019)
Semantic Scholar Logo Some data provided by SemanticScholar